| Evolution of poor reporting and inadequate methods over time in 20 920 randomised controlled trials included in Cochrane reviews: research on research study A Dechartres, L Trinquart, I Atal, D Moher, K Dickersin, I Boutron, ... Bmj 357, 2017 | 159 | 2017 |
| Differential globalization of industry-and non-industry–sponsored clinical trials I Atal, L Trinquart, R Porcher, P Ravaud PloS one 10 (12), e0145122, 2015 | 77 | 2015 |
| The statistical significance of meta-analyses is frequently fragile: definition of a fragility index for meta-analyses I Atal, R Porcher, I Boutron, P Ravaud Journal of clinical epidemiology 111, 32-40, 2019 | 76 | 2019 |
| Reporting quality of studies using machine learning models for medical diagnosis: a systematic review M Yusuf, I Atal, J Li, P Smith, P Ravaud, M Fergie, M Callaghan, J Selfe BMJ open 10 (3), e034568, 2020 | 73 | 2020 |
| Association between trial registration and treatment effect estimates: a meta-epidemiological study A Dechartres, P Ravaud, I Atal, C Riveros, I Boutron BMC medicine 14, 1-9, 2016 | 64 | 2016 |
| Avoidable waste of research related to outcome planning and reporting in clinical trials Y Yordanov, A Dechartres, I Atal, VT Tran, I Boutron, P Crequit, P Ravaud BMC medicine 16, 1-11, 2018 | 53 | 2018 |
| Association between publication characteristics and treatment effect estimates: a meta-epidemiologic study A Dechartres, I Atal, C Riveros, J Meerpohl, P Ravaud Annals of internal medicine 169 (6), 385-393, 2018 | 41 | 2018 |
| Automatic screening using word embeddings achieved high sensitivity and workload reduction for updating living network meta-analyses I Lerner, P Créquit, P Ravaud, I Atal Journal of clinical epidemiology 108, 86-94, 2019 | 29 | 2019 |
| A mapping of 115,000 randomized trials revealed a mismatch between research effort and health needs in non–high-income regions I Atal, L Trinquart, P Ravaud, R Porcher Journal of clinical epidemiology 98, 123-132, 2018 | 26 | 2018 |
| Disagreements in risk of bias assessment for randomised controlled trials included in more than one Cochrane systematic reviews: a research on research study using cross … L Bertizzolo, P Bossuyt, I Atal, P Ravaud, A Dechartres BMJ open 9 (4), e028382, 2019 | 25 | 2019 |
| Automatic classification of registered clinical trials towards the Global Burden of Diseases taxonomy of diseases and injuries I Atal, JD Zeitoun, A Névéol, P Ravaud, R Porcher, L Trinquart BMC bioinformatics 17, 1-14, 2016 | 19 | 2016 |
| Post‐marketing research and its outcome for novel anticancer agents approved by both the FDA and EMA between 2005 and 2010: A cross‐sectional study JD Zeitoun, G Baron, A Vivot, I Atal, NS Downing, JS Ross, P Ravaud International Journal of Cancer 142 (2), 414-423, 2018 | 15 | 2018 |
| Postmarketing studies for novel drugs approved by both the FDA and EMA between 2005 and 2010: a cross-sectional study JD Zeitoun, JS Ross, I Atal, A Vivot, NS Downing, G Baron, P Ravaud BMJ open 7 (12), e018587, 2017 | 13 | 2017 |
| Reporting of statistically significant results at ClinicalTrials. gov for completed superiority randomized controlled trials A Dechartres, EG Bond, J Scheer, C Riveros, I Atal, P Ravaud BMC medicine 14, 1-10, 2016 | 8 | 2016 |
| Reporting quality of studies using machine learning models for medical diagnosis: a systematic review. BMJ Open 10: e034568 M Yusuf, I Atal, J Li, P Smith, P Ravaud, M Fergie, M Callaghan, J Selfe | 7 | 2020 |
| Fragilty Index of meta-analyses I Atal, R Porcher, I Boutron, P Ravaud Paris, 2018 | 6 | 2018 |
| Ten years of interventional research in systemic sclerosis: a systematic mapping of trial registries M Iudici, A Bafeta, I Atal, P Ravaud Arthritis care & research 72 (1), 140-148, 2020 | 5 | 2020 |
| Factors associated with postmarketing research for Approved indications for novel medicines Approved by both the FDA and EMA between 2005 and 2010: a multivariable analysis JD Zeitoun, JS Ross, I Atal, A Vivot, NS Downing, G Baron, P Ravaud Clinical Pharmacology & Therapeutics 104 (5), 1000-1007, 2018 | 4 | 2018 |
| The impact of the ‘Teachers as Researchers’ programme on educators’ sense of efficacy, practice, and collaboration at work: Results from implementation in France 2020-21 M Pagnotta, N Jeune, M De Nicola, I Atal EdArXiv, 2022 | 3 | 2022 |
| Randomized clinical trials in ANCA-associated vasculitis: a systematic analysis of the WHO-International Clinical Trials Registry Platform M Iudici, X Puéchal, A Brigante, I Atal, C Gabay Orphanet journal of rare diseases 15, 1-8, 2020 | 2 | 2020 |
